"News of California-based biotechnology company, International Stem Cell Corporation’s (ISCO) clinical trial spread rapidly through online and print news and social media. Many PD patients and their families have questioned whether they should try to sign up for such a study."
This article points to "five key questions" that should be addressed before considering partaking: iospress.nl/ios_news/are-st...